The IL-1β Receptor Antagonist SER140 Postpones the Onset of Diabetes in Female Nonobese Diabetic Mice

Figure 4

Stereological analyses of NOD mice pancreata. (a) β-cell mass, (b) non-β-cell mass, (c) unstained endocrine cell mass, and (d) immune cell mass in vehicle and SER140 treated NOD mice. The average for each group is marked by horizontal lines ( = 18-19/group).

(a)

(b)

(c)

(d)